Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.
After a two year COVID-delay, close to 300 people enjoyed a fun-filled 10th anniversary celebration at the MIA Amie St Clair Ball.
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
Tasmanian skin cancer patients to benefit from increased prevention and awareness campaigns, and bolstered melanoma support services.
An unprecedented number of breakthroughs to be presented by MIA researchers at world's leading clinical oncology conference.
A message of thanks from Matthew Browne, Melanoma Institute Australia CEO, to everyone involved in Melanoma March. Funds raised allow our Personalised Immunotherapy Platform (PIP) Clinical Trial to commence.
The pair, who have both been diagnosed with melanoma, are keen to raise funds and awareness for melanoma and will be participating in Melanoma March Coolangatta.
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
Spirits were high as everyone enjoyed the return of physical Melanoma March events, and 'March Your Way' initiatives!
Prof Georgina Long and Prof Richard Scolyer, cycled from Albury to Wagga on Day 1 of Riverina Melanoma Ride.